Skip to NavigationSkip to content

News

AbbVie's big plans for its new rheumatoid arthritis drug have taken a knock after the release of Phase 3 revealed two patients deaths in the trial.
PrimeVigilance has launched its new visual identity together alongside a new website.
Research undertaken by the Royal College of Psychiatrists using data from NHS Digital has found that the number of psychiatrists available to people...
Eli Lilly has announced new Phase 3 data which further add to the efficacy profile of Cyramza (ramucirumab) in treating platinum-refractory advanced...
In a perfect example of the competitive nature of the pharmaceutical industry, just as one company posted success in one particular area, another...
AstraZeneca has revealed new data at the European Society of Medical Oncology (ESMO) on the efficacy of Tagrisso (osimertinib) in the first-line...
Teva has announced that its protracted search for a new CEO has finally come to end, as it revealed the appointment of Kåre Schultz. The decision to...
Following Deloitte's anaylsis of th return on R&D spend by biopgramaceutical companies, this report reveals the key difficulties faced, as well...
Novartis CEO to retire, Sanofi withdraws from Zika vaccine project, and trial is hlated after the first CAR T-associated death. Check out the week's...
Researchers from Queen University, Belfast, have discovered that aspirin may be able to reverse the effects of tooth decay. In tests in the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches